Organ-on-a-chip (OOC) technology aims to more accurately reproduce human physiology in vitro, addressing the limitations of current approaches. This field is advancing rapidly. Image Credit: CN Bio ...
Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, ...
For those considering adding Organ-on-a-chip (OOC) technology into the workflow, it may be unclear where to start. Firstly, using a commercially available solution, such as CN Bio's PhysioMimix ®, ...
The current drug discovery process is inefficient, with a significant number of drugs halting clinical trials, pending more investigational work to understand causality, or failing due to unforeseen ...
Ottawa, April 22, 2025 (GLOBE NEWSWIRE) -- The global organ-on-a-chip market size was valued at USD 159.48 billion in 2024 and is predicted to hit around USD 3242.34 billion by 2034, a study published ...
SARASOTA, Fla., June 10, 2025 /PRNewswire/ -- World Precision Instruments (WPI), the global leader in transepithelial electrical resistance (TEER) technology, in collaboration with SynVivo, a leader ...
CN Bio, announced the establishment of a strategic partnership with Pharmaron. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix ® technology across existing applications and ...
HOUSTON--(BUSINESS WIRE)--The Offshore Operators Committee (OOC) Oil & Gas Blockchain Consortium today announced the successful completion of its first pilot leveraging blockchain technology. The ...
HOUSTON--(BUSINESS WIRE)--The OOC Oil & Gas Blockchain Consortium today announced that it has engaged with GuildOne to successfully test the industry’s first blockchain application for Authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback